ENHERTU® Type II Variation Application Validated by EMA for the Treatment of HER2 Mutant Metastatic Non-Small Cell Lung Cancer
Submission based on DESTINY-Lung02 and DESTINY-Lung01 phase 2 trial results which showed Daiichi Sankyo and…
Submission based on DESTINY-Lung02 and DESTINY-Lung01 phase 2 trial results which showed Daiichi Sankyo and…
BANDAR SERI BEGAWAN, Brunei--(BUSINESS WIRE)--#Dell--Story Highlights: Dell Technologies’ compute, storage and cloud solutions help Brunei’s…
The content-to-commerce powerhouse rolls out dermatologist-verified skin analysis and award-winning virtual makeup try-on across its…
Secures Exclusive Global Rights to Potentially Best-in-Class Spinal Muscular Atrophy Gene Therapy from UMass Chan…
HAMILTON, Bermuda--(BUSINESS WIRE)--Everen Limited (”Everen”) announced today that George F. Hutchings, Senior Vice President and…
Brookfield Growth’s investment follows the previously announced Series D led by Partners Group SEATTLE--(BUSINESS WIRE)--#CLM--SirionLabs,…
KARIYA, Japan--(BUSINESS WIRE)--Toyota Boshoku Corporation will exhibit at CES 2023 to be held in Las…
ANSAN, South Korea--(BUSINESS WIRE)--#CES2033--Seoul Viosys (“SVC”) (KOSDAQ: 092190), a global manufacturer of optical semiconductor devices,…
DUBLIN--(BUSINESS WIRE)--The "South Korea e-Commerce Market: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)"…
DUBLIN--(BUSINESS WIRE)--The "Robot Software Global Market Report 2022: Ukraine-Russia War Impact" report has been added…